ONTOLOGY REPORT - ANNOTATIONS
Term: Pancreatic Neoplasms
Accession: RDO:0000193
browse the term
Definition: Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA).
Synonyms: exact_synonym: Cancer of Pancreas; Cancer of the Pancreas; PANCREATIC ACINAR CARCINOMA; PANCREATIC CANCER, SUSCEPTIBILITY TO, 1; PANCREATIC CANCER, SUSCEPTIBILITY TO, 2; PANCREATIC CANCER, SUSCEPTIBILITY TO, 3; PANCREATIC CARCINOMA; PNCA1; PNCA2; PNCA3; Pancreas Cancer; Pancreas Cancers; Pancreas Neoplasm; Pancreas Neoplasms; Pancreatic Cancer; Pancreatic Cancers; Pancreatic Neoplasm
primary_id: MESH:D010190
alt_id: OMIM:260350 ; OMIM:606856 ; OMIM:613347 ; OMIM:613348
Pancreatic Neoplasms
G
A4gnt
alpha-1,4-N-acetylglucosaminyltransferase
ISS
9
99,512,921
99,522,786
RGD:2325199
RGD
G
Abcc2
ATP-binding cassette, sub-family C (CFTR/MRP), member 2
ISS
19
43,856,798
43,912,708
RGD:2317509
RGD
G
Abcc3
ATP-binding cassette, sub-family C (CFTR/MRP), member 3
Severity
ISS
11
94,204,609
94,254,290
RGD:2325200
RGD
G
Abcc5
ATP-binding cassette, sub-family C (CFTR/MRP), member 5
ISS
16
20,331,376
20,426,467
RGD:2325200
RGD
G
Abo
ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase, transferase B, alpha 1-3-galactosyltransferase)
ISS
2
26,698,023
26,720,499
RGD:2317511
RGD
G
Ace
angiotensin I converting enzyme (peptidyl-dipeptidase A) 1
IPM
11
105,829,261
105,851,259
RGD:2325208
RGD
G
Acvr1
activin A receptor, type 1
ISS
2
58,298,849
58,419,239
RGD:2317217
RGD
G
Acvr1b
activin A receptor, type 1B
ISS
15
101,004,556
101,043,032
RGD:2317217
RGD
G
Acvr1b
activin A receptor, type 1B
ISS
15
101,004,556
101,043,032
RGD:1598735
RGD
G
Acvr2a
activin receptor IIA
ISS
2
48,669,629
48,758,784
RGD:2317217
RGD
G
Adam15
a disintegrin and metallopeptidase domain 15 (metargidin)
ISS
3
89,143,562
89,153,932
RGD:2325247
RGD
G
Adam9
a disintegrin and metallopeptidase domain 9 (meltrin gamma)
ISS
8
26,060,083
26,127,394
RGD:2325247
RGD
G
Adh1
alcohol dehydrogenase 1 (class I)
ISS
3
137,940,609
137,953,655
RGD:2325313
RGD
G
Adm
adrenomedullin
Disease_progression
ISS
7
117,771,183
117,773,333
RGD:2325317
RGD
G
Adm
adrenomedullin
ISS
7
117,771,183
117,773,333
RGD:2325318
RGD
G
Ager
advanced glycosylation end product-specific receptor
ISS
17
34,734,807
34,737,877
RGD:2325643
RGD
G
Agtr2
angiotensin II receptor, type 2
ISS
X
21,061,752
21,065,957
RGD:2325641
RGD
G
Ahr
aryl-hydrocarbon receptor
ISS
12
36,182,651
36,219,661
RGD:2325664
RGD
G
Akt2
thymoma viral proto-oncogene 2
ISS
7
28,376,579
28,424,472
RGD:2290476
RGD
G
Akt2
thymoma viral proto-oncogene 2
ISS
7
28,376,579
28,424,472
RGD:5490965
RGD
G
Alb
albumin
Disease_progression
ISS
5
90,889,915
90,905,629
RGD:2325675
RGD
G
Alb
albumin
Disease_progression
ISS
5
90,889,915
90,905,629
RGD:2325678
RGD
G
Aldh1a1
aldehyde dehydrogenase family 1, subfamily A1
ISS
19
20,676,472
20,717,952
RGD:2325688
RGD
G
Aldh2
aldehyde dehydrogenase 2, mitochondrial
Susceptibility
ISS
5
122,017,696
122,043,833
RGD:2325694
RGD
G
Aldh2
aldehyde dehydrogenase 2, mitochondrial
Susceptibility
ISS
5
122,017,696
122,043,833
RGD:2325313
RGD
G
Alox5
arachidonate 5-lipoxygenase
ISS
6
116,360,089
116,411,196
RGD:2317523
RGD
G
Alox5
arachidonate 5-lipoxygenase
ISS
6
116,360,089
116,411,196
RGD:2317524
RGD
G
Ang
angiogenin, ribonuclease, RNase A family, 5
Disease_progression
ISS
14
51,710,752
51,721,684
RGD:2325716
RGD
G
Anxa1
annexin A1
ISS
19
20,447,924
20,465,161
RGD:2325722
RGD
G
Anxa1
annexin A1
ISS
19
20,447,924
20,465,161
RGD:2325723
RGD
G
Apaf1
apoptotic peptidase activating factor 1
ISS
10
90,452,056
90,545,488
RGD:2325739
RGD
G
Apc
adenomatosis polyposis coli
ISS
18
34,380,638
34,481,844
RGD:2317208
RGD
G
Apc
adenomatosis polyposis coli
IAGP
18
34,380,638
34,481,844
RGD:2317207
RGD
G
Apoa1
apolipoprotein A-I
ISS
9
46,036,713
46,038,549
RGD:2325758
RGD
G
Apoa1
apolipoprotein A-I
ISS
9
46,036,713
46,038,549
RGD:2325757
RGD
G
Apoe
apolipoprotein E
IEP
7
20,281,593
20,284,515
RGD:2317552
RGD
G
Arpc1a
actin related protein 2/3 complex, subunit 1A
ISS
5
145,844,738
145,869,625
RGD:2317557
RGD
G
Artn
artemin
ISS
4
117,598,767
117,602,368
RGD:2325815
RGD
G
Artn
artemin
Disease_progression
ISS
4
117,598,767
117,602,368
RGD:2325817
RGD
G
Atm
ataxia telangiectasia mutated homolog (human)
ISS
9
53,245,227
53,344,776
RGD:2317234
RGD
G
Atm
ataxia telangiectasia mutated homolog (human)
Susceptibility
ISS
9
53,245,227
53,344,776
RGD:2317363
RGD
G
Atm
ataxia telangiectasia mutated homolog (human)
ISS
9
53,245,227
53,344,776
RGD:2317367
RGD
G
Atr
ataxia telangiectasia and Rad3 related
ISS
9
95,758,016
95,852,063
RGD:2317234
RGD
G
B3galt5
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5
ISS
16
96,457,408
96,541,465
RGD:2317558
RGD
G
Bag3
BCL2-associated athanogene 3
ISS
7
135,667,097
135,690,495
RGD:2325843
RGD
G
Bag4
BCL2-associated athanogene 4
ISS
8
26,875,010
26,895,681
RGD:2325852
RGD
G
Bid
BH3 interacting domain death agonist
ISS
6
120,843,137
120,866,838
RGD:2317560
RGD
G
Boc
biregional cell adhesion molecule-related/down-regulated by oncogenes (Cdon) binding protein
ISS
16
44,485,158
44,558,983
RGD:5490966
RGD
G
Brca2
breast cancer 2
ISS
5
151,325,198
151,372,324
RGD:7240710
OMIM
G
Bub1b
budding uninhibited by benzimidazoles 1 homolog, beta (S. cerevisiae)
ISS
2
118,423,947
118,467,328
RGD:2326105
RGD
G
Cacybp
calcyclin binding protein
Disease_progression
ISS
1
162,133,052
162,142,908
RGD:2326146
RGD
G
Cap1
CAP, adenylate cyclase-associated protein 1 (yeast)
Disease_progression
ISS
4
122,536,471
122,563,124
RGD:2326238
RGD
G
Capn10
calpain 10
Susceptibility
ISS
1
94,830,985
94,844,525
RGD:4107073
RGD
G
Casp8
caspase 8
Susceptibility
ISS
1
58,852,218
58,904,347
RGD:2315744
RGD
G
Casp8
caspase 8
ISS
1
58,852,218
58,904,347
RGD:2317230
RGD
G
Cat
catalase
Disease_progression
ISS
2
103,294,061
103,325,310
RGD:2317410
RGD
G
Cckar
cholecystokinin A receptor
ISS
5
54,089,724
54,098,943
RGD:4110817
RGD
G
Cckar
cholecystokinin A receptor
ISS
5
54,089,724
54,098,943
RGD:4110822
RGD
G
Cckbr
cholecystokinin B receptor
ISS
7
112,574,334
112,584,852
RGD:4110822
RGD
G
Cckbr
cholecystokinin B receptor
Susceptibility
ISS
7
112,574,334
112,584,852
RGD:4110829
RGD
G
Cckbr
cholecystokinin B receptor
ISS
7
112,574,334
112,584,852
RGD:4110821
RGD
G
Cckbr
cholecystokinin B receptor
Disease_progression
ISS
7
112,574,334
112,584,852
RGD:4110823
RGD
G
Ccl5
chemokine (C-C motif) ligand 5
IPM
11
83,339,280
83,344,020
RGD:2317567
RGD
G
Ccr4
chemokine (C-C motif) receptor 4
ISS
9
114,399,434
114,405,662
RGD:2317610
RGD
G
Ccr5
chemokine (C-C motif) receptor 5
IPM
9
124,036,282
124,041,922
RGD:2317567
RGD
G
Cd97
CD97 antigen
ISS
8
86,247,150
86,265,210
RGD:2317573
RGD
G
Cftr
cystic fibrosis transmembrane conductance regulator
No_Association
ISS
6
18,120,687
18,272,770
RGD:2317157
RGD
G
Cftr
cystic fibrosis transmembrane conductance regulator
Onset
ISS
6
18,120,687
18,272,770
RGD:2317156
RGD
G
Chek1
checkpoint kinase 1
Disease_progression
ISS
9
36,516,067
36,534,243
RGD:2317234
RGD
G
Cldn4
claudin 4
ISS
5
135,420,993
135,422,804
RGD:2317583
RGD
G
Cldn4
claudin 4
ISS
5
135,420,993
135,422,804
RGD:2317580
RGD
G
Cycs
cytochrome c, somatic
ISS
6
50,512,562
50,516,473
RGD:2317614
RGD
G
Cyp17a1
cytochrome P450, family 17, subfamily a, polypeptide 1
Susceptibility
ISS
19
46,741,655
46,747,490
RGD:2317618
RGD
G
Dpyd
dihydropyrimidine dehydrogenase
ISS
3
118,265,096
119,135,836
RGD:2317630
RGD
G
Dpyd
dihydropyrimidine dehydrogenase
Disease_progression
ISS
3
118,265,096
119,135,836
RGD:2317629
RGD
G
Egf
epidermal growth factor
ISS
3
129,380,493
129,458,240
RGD:5490965
RGD
G
Egf
epidermal growth factor
Disease_progression
ISS
3
129,380,493
129,458,240
RGD:2317650
RGD
G
Egfr
epidermal growth factor receptor
ISS
11
16,652,206
16,813,910
RGD:5490965
RGD
G
Egfr
epidermal growth factor receptor
ISS
11
16,652,206
16,813,910
RGD:5131631
RGD
G
Epha3
Eph receptor A3
ISS
16
63,545,044
63,863,983
RGD:2317720
RGD
G
Ercc2
excision repair cross-complementing rodent repair deficiency, complementation group 2
ISS
7
19,967,388
19,981,041
RGD:2317228
RGD
G
Ercc2
excision repair cross-complementing rodent repair deficiency, complementation group 2
ISS
7
19,967,388
19,981,041
RGD:2317223
RGD
G
Ercc4
excision repair cross-complementing rodent repair deficiency, complementation group 4
ISS
16
13,109,829
13,152,102
RGD:2317223
RGD
G
Fanca
Fanconi anemia, complementation group A
ISS
8
125,792,144
125,842,476
RGD:2317735
RGD
G
Fancc
Fanconi anemia, complementation group C
ISS
13
63,406,017
63,533,053
RGD:2317239
RGD
G
Fancc
Fanconi anemia, complementation group C
ISS
13
63,406,017
63,533,053
RGD:2317238
RGD
G
Fancg
Fanconi anemia, complementation group G
ISS
4
43,015,209
43,023,173
RGD:2317238
RGD
G
Fasl
Fas ligand (TNF superfamily, member 6)
ISS
1
163,710,820
163,718,626
RGD:2317745
RGD
G
Fasl
Fas ligand (TNF superfamily, member 6)
Resistance
ISS
1
163,710,820
163,718,626
RGD:2315744
RGD
G
Fasl
Fas ligand (TNF superfamily, member 6)
Severity
ISS
1
163,710,820
163,718,626
RGD:2317744
RGD
G
Fgf2
fibroblast growth factor 2
ISS
3
37,247,575
37,303,752
RGD:2317762
RGD
G
Fgf2
fibroblast growth factor 2
ISS
3
37,247,575
37,303,752
RGD:2317765
RGD
G
Fgf2
fibroblast growth factor 2
ISS
3
37,247,575
37,303,752
RGD:2317759
RGD
G
Fgf2
fibroblast growth factor 2
ISS
3
37,247,575
37,303,752
RGD:2317760
RGD
G
Fscn1
fascin homolog 1, actin bundling protein (Strongylocentrotus purpuratus)
Severity
ISS
5
143,722,034
143,734,868
RGD:2317785
RGD
G
Gdnf
glial cell line derived neurotrophic factor
Severity
ISS
15
7,761,011
7,787,575
RGD:2324925
RGD
G
Gli1
GLI-Kruppel family member GLI1
ISS
10
126,766,938
126,778,635
RGD:5491005
RGD
G
Gli1
GLI-Kruppel family member GLI1
ISS
10
126,766,938
126,778,635
RGD:5490966
RGD
G
Gli3
GLI-Kruppel family member GLI3
ISS
13
15,555,556
15,821,859
RGD:5490966
RGD
G
Gnas
GNAS (guanine nucleotide binding protein, alpha stimulating) complex locus
ISS
2
174,109,821
174,172,245
RGD:2317256
RGD
G
Gstp1
glutathione S-transferase, pi 1
ISS
19
4,035,411
4,037,912
RGD:2317805
RGD
G
Gstp1
glutathione S-transferase, pi 1
Susceptibility
ISS
19
4,035,411
4,037,912
RGD:2317804
RGD
G
Hgf
hepatocyte growth factor
ISS
5
16,059,368
16,125,257
RGD:2317895
RGD
G
Hs3st2
heparan sulfate (glucosamine) 3-O-sulfotransferase 2
ISS
7
128,535,810
128,645,282
RGD:2317633
RGD
G
Icam1
intercellular adhesion molecule 1
ISS
9
20,820,404
20,833,241
RGD:2325165
RGD
G
Ifng
interferon gamma
ISS
10
117,878,103
117,882,948
RGD:2317258
RGD
G
Igf1
insulin-like growth factor 1
Susceptibility
ISS
10
87,321,801
87,399,792
RGD:2306689
RGD
G
Igf1r
insulin-like growth factor I receptor
ISS
7
75,097,143
75,378,553
RGD:2317651
RGD
G
Igf1r
insulin-like growth factor I receptor
ISS
7
75,097,143
75,378,553
RGD:2317642
RGD
G
Igf1r
insulin-like growth factor I receptor
ISS
7
75,097,143
75,378,553
RGD:2317640
RGD
G
Il10
interleukin 10
ISS
1
132,916,422
132,921,547
RGD:2317655
RGD
G
Il10
interleukin 10
Susceptibility
ISS
1
132,916,422
132,921,547
RGD:2317653
RGD
G
Il13
interleukin 13
Disease_progression
ISS
11
53,444,825
53,448,204
RGD:2317669
RGD
G
Il13
interleukin 13
ISS
11
53,444,825
53,448,204
RGD:2317670
RGD
G
Il1a
interleukin 1 alpha
ISS
2
129,125,346
129,135,708
RGD:2311069
RGD
G
Il1a
interleukin 1 alpha
ISS
2
129,125,346
129,135,708
RGD:2317657
RGD
G
Il1b
interleukin 1 beta
ISS
2
129,190,315
129,196,856
RGD:2311069
RGD
G
Il1b
interleukin 1 beta
Susceptibility
ISS
2
129,190,315
129,196,856
RGD:2317215
RGD
G
Il3
interleukin 3
ISS
11
54,078,587
54,080,781
RGD:2317663
RGD
G
Il4
interleukin 4
Disease_progression
ISS
11
53,425,962
53,432,167
RGD:2317261
RGD
G
Il4
interleukin 4
IED
11
53,425,962
53,432,167
RGD:2317267
RGD
G
Il4
interleukin 4
ISS
11
53,425,962
53,432,167
RGD:2317265
RGD
G
Il4ra
interleukin 4 receptor, alpha
Disease_progression
ISS
7
132,695,796
132,722,988
RGD:2317669
RGD
G
Ins2
insulin II
IED
7
149,864,561
149,865,613
RGD:2317245
RGD
G
Ins2
insulin II
Susceptibility
ISS
7
149,864,561
149,865,613
RGD:2317250
RGD
G
Ins2
insulin II
Susceptibility
ISS
7
149,864,561
149,865,613
RGD:2317247
RGD
G
Ins2
insulin II
Disease_progression
ISS
7
149,864,561
149,865,613
RGD:2317253
RGD
G
Kdr
kinase insert domain protein receptor
ISS
5
76,329,290
76,374,453
RGD:5684397
RGD
G
Kras
v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog
ISS
6
145,165,219
145,198,751
RGD:5490965
RGD
G
Kras
v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog
ISS
6
145,165,219
145,198,751
RGD:5490966
RGD
G
Kras
v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog
Disease_progression
ISS
6
145,165,219
145,198,751
RGD:1581761
RGD
G
Kras
v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog
ISS
6
145,165,219
145,198,751
RGD:7240710
OMIM
G
Lig3
ligase III, DNA, ATP-dependent
Resistance
ISS
11
82,594,637
82,617,776
RGD:2317363
RGD
G
Lig4
ligase IV, DNA, ATP-dependent
Susceptibility
ISS
8
9,970,020
9,976,323
RGD:2317363
RGD
G
Lrp2
low density lipoprotein receptor-related protein 2
ISS
2
69,262,392
69,424,124
RGD:5490966
RGD
G
Lum
lumican
Disease_progression
ISS
10
97,028,135
97,035,337
RGD:2317682
RGD
G
Lum
lumican
Disease_progression
ISS
10
97,028,135
97,035,337
RGD:2317230
RGD
G
Manf
mesencephalic astrocyte-derived neurotrophic factor
No_Association
ISS
9
106,789,746
106,794,269
RGD:2317157
RGD
G
Manf
mesencephalic astrocyte-derived neurotrophic factor
ISS
9
106,789,746
106,794,269
RGD:2325804
RGD
G
Map2k4
mitogen-activated protein kinase kinase 4
ISS
11
65,501,746
65,601,799
RGD:5490966
RGD
G
Men1
multiple endocrine neoplasia 1
ISS
19
6,334,979
6,340,894
RGD:2317340
RGD
G
Met
met proto-oncogene
ISS
6
17,413,957
17,523,980
RGD:5490965
RGD
G
Met
met proto-oncogene
Severity
ISS
6
17,413,957
17,523,980
RGD:2317235
RGD
G
Met
met proto-oncogene
ISS
6
17,413,957
17,523,980
RGD:2317613
RGD
G
Mgat4a
mannoside acetylglucosaminyltransferase 4, isoenzyme A
ISS
1
37,496,185
37,593,104
RGD:2317701
RGD
G
Mgmt
O-6-methylguanine-DNA methyltransferase
ISS
7
144,086,294
144,319,871
RGD:2317628
RGD
G
Mki67
antigen identified by monoclonal antibody Ki 67
ISS
7
142,881,471
142,908,062
RGD:2317704
RGD
G
Mki67
antigen identified by monoclonal antibody Ki 67
Disease_progression
ISS
7
142,881,471
142,908,062
RGD:2317703
RGD
G
Mmp2
matrix metallopeptidase 2
ISS
8
95,351,227
95,377,319
RGD:2325752
RGD
G
Mmp2
matrix metallopeptidase 2
ISS
8
95,351,227
95,377,319
RGD:2325766
RGD
G
Mmp9
matrix metallopeptidase 9
ISS
2
164,773,751
164,781,346
RGD:2325766
RGD
G
Mmp9
matrix metallopeptidase 9
Disease_progression
ISS
2
164,773,751
164,781,346
RGD:2325831
RGD
G
Mmp9
matrix metallopeptidase 9
IPM
2
164,773,751
164,781,346
RGD:2325849
RGD
G
Mmp9
matrix metallopeptidase 9
IPM
2
164,773,751
164,781,346
RGD:2325854
RGD
G
Mpo
myeloperoxidase
Resistance
ISS
11
87,607,286
87,617,914
RGD:2317406
RGD
G
Msln
mesothelin
ISS
17
25,885,558
25,891,272
RGD:2326052
RGD
G
Msln
mesothelin
ISS
17
25,885,558
25,891,272
RGD:2326060
RGD
G
Msln
mesothelin
ISS
17
25,885,558
25,891,272
RGD:2326062
RGD
G
Msln
mesothelin
ISS
17
25,885,558
25,891,272
RGD:2326056
RGD
G
Mtap
methylthioadenosine phosphorylase
ISS
4
88,783,274
88,826,994
RGD:2317952
RGD
G
Mthfr
5,10-methylenetetrahydrofolate reductase
Susceptibility
ISS
4
147,413,186
147,433,671
RGD:2317120
RGD
G
Mtr
5-methyltetrahydrofolate-homocysteine methyltransferase
Susceptibility
ISS
13
12,279,086
12,350,267
RGD:2317118
RGD
G
Mtr
5-methyltetrahydrofolate-homocysteine methyltransferase
No_Association
ISS
13
12,279,086
12,350,267
RGD:2317120
RGD
G
Mtrr
5-methyltetrahydrofolate-homocysteine methyltransferase reductase
ISS
13
68,699,657
68,720,998
RGD:2317118
RGD
G
Mtrr
5-methyltetrahydrofolate-homocysteine methyltransferase reductase
Susceptibility
ISS
13
68,699,657
68,720,998
RGD:2325772
RGD
G
Muc1
mucin 1, transmembrane
Disease_progression
ISS
3
89,032,974
89,037,291
RGD:2317984
RGD
G
Muc1
mucin 1, transmembrane
ISS
3
89,032,974
89,037,291
RGD:2324639
RGD
G
Muc1
mucin 1, transmembrane
ISS
3
89,032,974
89,037,291
RGD:2324635
RGD
G
Muc1
mucin 1, transmembrane
ISS
3
89,032,974
89,037,291
RGD:2317987
RGD
G
Muc1
mucin 1, transmembrane
ISS
3
89,032,974
89,037,291
RGD:2324637
RGD
G
Muc1
mucin 1, transmembrane
ISS
3
89,032,974
89,037,291
RGD:2324622
RGD
G
Muc16
mucin 16
ISS
9
18,299,899
18,317,332
RGD:2325129
RGD
G
Muc4
mucin 4
ISS
16
32,735,972
32,782,477
RGD:2324891
RGD
G
Muc4
mucin 4
ISS
16
32,735,972
32,782,477
RGD:2324931
RGD
G
Muc4
mucin 4
Disease_progression
ISS
16
32,735,972
32,782,477
RGD:2324923
RGD
G
Muc4
mucin 4
ISS
16
32,735,972
32,782,477
RGD:2324922
RGD
G
Muc4
mucin 4
ISS
16
32,735,972
32,782,477
RGD:2324914
RGD
G
Muc5ac
mucin 5, subtypes A and C, tracheobronchial/gastric
ISS
7
148,974,916
149,005,040
RGD:2317984
RGD
G
Muc5ac
mucin 5, subtypes A and C, tracheobronchial/gastric
ISS
7
148,974,916
149,005,040
RGD:2325129
RGD
G
Muc6
mucin 6, gastric
ISS
7
148,819,948
148,841,207
RGD:2325167
RGD
G
Myc
myelocytomatosis oncogene
IPM
15
61,816,896
61,821,916
RGD:7240699
RGD
G
Nat1
N-acetyl transferase 1
Susceptibility
ISS
8
70,014,657
70,016,003
RGD:2317168
RGD
G
Nat1
N-acetyl transferase 1
ISS
8
70,014,657
70,016,003
RGD:2317170
RGD
G
Nat2
N-acetyltransferase 2 (arylamine N-acetyltransferase)
Susceptibility
ISS
8
70,018,774
70,026,479
RGD:2317169
RGD
G
Ncam1
neural cell adhesion molecule 1
Disease_progression
ISS
9
49,310,243
49,607,174
RGD:2326074
RGD
G
Ncam1
neural cell adhesion molecule 1
Severity
ISS
9
49,310,243
49,607,174
RGD:2326075
RGD
G
Ngfr
nerve growth factor receptor (TNFR superfamily, member 16)
Severity
ISS
11
95,430,132
95,449,012
RGD:5508229
RGD
G
Nos2
nitric oxide synthase 2, inducible
Disease_progression
IPM
11
78,734,361
78,773,626
RGD:2325262
RGD
G
Nos2
nitric oxide synthase 2, inducible
ISS
11
78,734,361
78,773,626
RGD:2325248
RGD
G
Nos2
nitric oxide synthase 2, inducible
Disease_progression
IED
11
78,734,361
78,773,626
RGD:2325257
RGD
G
Notch1
notch 1
Disease_progression
IPM
2
26,313,422
26,359,342
RGD:2325328
RGD
G
Ntrk1
neurotrophic tyrosine kinase, receptor, type 1
Severity
ISS
3
87,582,166
87,599,084
RGD:5508229
RGD
G
Ntrk3
neurotrophic tyrosine kinase, receptor, type 3
ISS
7
85,337,000
85,722,724
RGD:2325656
RGD
G
Ogg1
8-oxoguanine DNA-glycosylase 1
ISS
6
113,276,970
113,284,182
RGD:2317130
RGD
G
Ogg1
8-oxoguanine DNA-glycosylase 1
Disease_progression
ISS
6
113,276,970
113,284,182
RGD:2317132
RGD
G
Palb2
partner and localizer of BRCA2
Susceptibility
ISS
7
129,250,779
129,276,460
RGD:2325776
RGD
G
Palb2
partner and localizer of BRCA2
ISS
7
129,250,779
129,276,460
RGD:7240710
OMIM
G
Palld
palladin, cytoskeletal associated protein
IEP
8
63,993,818
64,381,487
RGD:2325779
RGD
G
Palld
palladin, cytoskeletal associated protein
ISS
8
63,993,818
64,381,487
RGD:2325782
RGD
G
Palld
palladin, cytoskeletal associated protein
ISS
8
63,993,818
64,381,487
RGD:7240710
OMIM
G
Pdgfra
platelet derived growth factor receptor, alpha polypeptide
ISS
5
75,548,316
75,594,229
RGD:2324850
RGD
G
Pdgfra
platelet derived growth factor receptor, alpha polypeptide
ISS
5
75,548,316
75,594,229
RGD:2324851
RGD
G
Pfn1
profilin 1
ISS
11
70,465,349
70,468,152
RGD:2317552
RGD
G
Polb
polymerase (DNA directed), beta
Disease_progression
ISS
8
23,738,591
23,763,909
RGD:2317132
RGD
G
Ppard
peroxisome proliferator activator receptor delta
IPM
17
28,369,699
28,438,414
RGD:2324872
RGD
G
Pparg
peroxisome proliferator activated receptor gamma
ISS
6
115,311,239
115,440,419
RGD:2317462
RGD
G
Pparg
peroxisome proliferator activated receptor gamma
Susceptibility
ISS
6
115,311,239
115,440,419
RGD:2317460
RGD
G
Ptch1
patched homolog 1
ISS
13
63,612,841
63,666,828
RGD:2324910
RGD
G
Pten
phosphatase and tensin homolog
ISS
19
32,832,067
32,900,650
RGD:5490965
RGD
G
Ptgs2
prostaglandin-endoperoxide synthase 2
Susceptibility
ISS
1
151,947,254
151,955,147
RGD:5135527
RGD
G
Ptgs2
prostaglandin-endoperoxide synthase 2
Susceptibility
ISS
1
151,947,254
151,955,147
RGD:2317184
RGD
G
Ptgs2
prostaglandin-endoperoxide synthase 2
ISS
1
151,947,254
151,955,147
RGD:2317179
RGD
G
Ptgs2
prostaglandin-endoperoxide synthase 2
ISS
1
151,947,254
151,955,147
RGD:2317175
RGD
G
Rad54l
RAD54 like (S. cerevisiae)
ISS
4
115,769,560
115,796,295
RGD:2317365
RGD
G
Recql
RecQ protein-like
ISS
6
142,310,420
142,335,607
RGD:2317369
RGD
G
Recql
RecQ protein-like
ISS
6
142,310,420
142,335,607
RGD:2317365
RGD
G
Recql
RecQ protein-like
ISS
6
142,310,420
142,335,607
RGD:2317370
RGD
G
Rela
v-rel reticuloendotheliosis viral oncogene homolog A (avian)
ISS
19
5,637,490
5,648,130
RGD:2298892
RGD
G
Ret
ret proto-oncogene
Disease_progression
ISS
6
118,101,766
118,147,762
RGD:2324926
RGD
G
Rrm2
ribonucleotide reductase M2
ISS
12
25,393,119
25,399,011
RGD:2324950
RGD
G
Runx3
runt related transcription factor 3
Disease_progression
ISS
4
134,676,560
134,733,905
RGD:2324956
RGD
G
Rxra
retinoid X receptor alpha
ISS
2
27,532,721
27,618,839
RGD:2317462
RGD
G
Sel1l
sel-1 suppressor of lin-12-like (C. elegans)
ISS
12
93,044,483
93,087,597
RGD:2317190
RGD
G
Serpina1e
serine (or cysteine) peptidase inhibitor, clade A, member 1E
Disease_progression
ISS
12
105,185,141
105,195,107
RGD:2324960
RGD
G
Shh
sonic hedgehog
ISS
5
28,783,380
28,793,641
RGD:5490965
RGD
G
Smo
smoothened homolog (Drosophila)
ISS
6
29,685,497
29,711,366
RGD:2324910
RGD
G
Smo
smoothened homolog (Drosophila)
IPM
6
29,685,497
29,711,366
RGD:2324978
RGD
G
Smurf1
SMAD specific E3 ubiquitin protein ligase 1
ISS
5
145,637,364
145,726,699
RGD:2302550
RGD
G
Sncg
synuclein, gamma
ISS
14
35,183,460
35,187,855
RGD:6478801
RGD
G
Sod1
superoxide dismutase 1, soluble
ISS
16
90,220,987
90,226,569
RGD:2317410
RGD
G
Sod2
superoxide dismutase 2, mitochondrial
ISS
17
13,200,705
13,210,985
RGD:1581235
RGD
G
Sod2
superoxide dismutase 2, mitochondrial
Susceptibility
ISS
17
13,200,705
13,210,985
RGD:2317406
RGD
G
Sod2
superoxide dismutase 2, mitochondrial
Disease_progression
ISS
17
13,200,705
13,210,985
RGD:2317410
RGD
G
Spp1
secreted phosphoprotein 1
ISS
5
104,869,403
104,879,477
RGD:1581363
RGD
G
Stk11
serine/threonine kinase 11
ISS
10
79,579,281
79,593,215
RGD:7240710
OMIM
G
Tgfa
transforming growth factor alpha
ISS
6
86,145,245
86,225,443
RGD:5490965
RGD
G
Tgfa
transforming growth factor alpha
ISS
6
86,145,245
86,225,443
RGD:2317468
RGD
G
Tgfa
transforming growth factor alpha
ISS
6
86,145,245
86,225,443
RGD:2317473
RGD
G
Tgfb1
transforming growth factor, beta 1
Disease_progression
ISS
7
26,472,021
26,490,015
RGD:2325015
RGD
G
Tgfb1
transforming growth factor, beta 1
Disease_progression
ISS
7
26,472,021
26,490,015
RGD:2325018
RGD
G
Tgfbr2
transforming growth factor, beta receptor II
Disease_progression
ISS
9
115,996,813
116,084,481
RGD:2317502
RGD
G
Tgfbr2
transforming growth factor, beta receptor II
ISS
9
115,996,813
116,084,481
RGD:2317501
RGD
G
Tgfbr2
transforming growth factor, beta receptor II
ISS
9
115,996,813
116,084,481
RGD:2317499
RGD
G
Thbs1
thrombospondin 1
ISS
2
117,937,658
117,952,869
RGD:2325023
RGD
G
Thbs1
thrombospondin 1
Disease_progression
ISS
2
117,937,658
117,952,869
RGD:2325021
RGD
G
Thbs1
thrombospondin 1
ISS
2
117,937,658
117,952,869
RGD:2325028
RGD
G
Trp53
transformation related protein 53
ISS
11
69,393,861
69,405,375
RGD:5490966
RGD
G
Trp53
transformation related protein 53
ISS
11
69,393,861
69,405,375
RGD:7240710
OMIM
G
Trp53bp1
transformation related protein 53 binding protein 1
IPM
2
121,022,463
121,097,122
RGD:2325154
RGD
G
Tymp
thymidine phosphorylase
ISS
15
89,202,362
89,207,467
RGD:2325156
RGD
G
Uck2
uridine-cytidine kinase 2
ISS
1
169,156,214
169,215,258
RGD:5133269
RGD
G
Ugt1a7c
UDP glucuronosyltransferase 1 family, polypeptide A7C
ISS
1
89,991,576
90,116,577
RGD:2317503
RGD
G
Ugt1a7c
UDP glucuronosyltransferase 1 family, polypeptide A7C
No_Association
ISS
1
89,991,576
90,116,577
RGD:2317157
RGD
G
Vcam1
vascular cell adhesion molecule 1
ISS
3
115,812,938
115,832,606
RGD:2325162
RGD
G
Vhl
von Hippel-Lindau tumor suppressor
ISS
6
113,574,015
113,581,627
RGD:2325176
RGD
G
Vhl
von Hippel-Lindau tumor suppressor
ISS
6
113,574,015
113,581,627
RGD:2325169
RGD
G
Xpc
xeroderma pigmentosum, complementation group C
ISS
6
91,439,299
91,465,882
RGD:2317130
RGD
G
Xrcc1
X-ray repair complementing defective repair in Chinese hamster cells 1
ISS
7
25,332,169
25,358,457
RGD:2317367
RGD
G
Xrcc2
X-ray repair complementing defective repair in Chinese hamster cells 2
ISS
5
25,195,632
25,211,615
RGD:2317365
RGD
G
Xrcc2
X-ray repair complementing defective repair in Chinese hamster cells 2
ISS
5
25,195,632
25,211,615
RGD:2317507
RGD
G
Xrcc3
X-ray repair complementing defective repair in Chinese hamster cells 3
ISS
12
113,041,404
113,052,052
RGD:2317130
RGD
Adenoma, Islet Cell
G
Pcsk1
proprotein convertase subtilisin/kexin type 1
ISS
13
75,227,435
75,269,946
RGD:2308920
RGD
Carcinoma, Islet Cell
G
Mgmt
O-6-methylguanine-DNA methyltransferase
ISS
7
144,086,294
144,319,871
RGD:2317661
RGD
Carcinoma, Pancreatic Ductal
G
Ace
angiotensin I converting enzyme (peptidyl-dipeptidase A) 1
ISS
11
105,829,261
105,851,259
RGD:2325211
RGD
G
Ace2
angiotensin I converting enzyme (peptidyl-dipeptidase A) 2
ISS
X
160,577,274
160,626,350
RGD:2325210
RGD
G
Adam8
a disintegrin and metallopeptidase domain 8
Disease_progression
ISS
7
147,164,840
147,178,387
RGD:2325243
RGD
G
Adam9
a disintegrin and metallopeptidase domain 9 (meltrin gamma)
Disease_progression
ISS
8
26,060,083
26,127,394
RGD:2325249
RGD
G
Agr2
anterior gradient 2 (Xenopus laevis)
ISS
12
36,719,512
36,730,668
RGD:2325659
RGD
G
Alb
albumin
Disease_progression
ISS
5
90,889,915
90,905,629
RGD:2325677
RGD
G
Anxa2
annexin A2
ISS
9
69,301,490
69,339,592
RGD:2325731
RGD
G
Anxa2
annexin A2
Disease_progression
ISS
9
69,301,490
69,339,592
RGD:2317307
RGD
G
Anxa5
annexin A5
ISS
3
36,347,845
36,374,809
RGD:2317538
RGD
G
Anxa8
annexin A8
ISS
14
34,899,176
34,913,757
RGD:2325735
RGD
G
Apoc1
apolipoprotein C-I
ISS
7
20,274,830
20,278,007
RGD:2325793
RGD
G
Calr
calreticulin
ISS
8
87,365,987
87,370,830
RGD:2326165
RGD
G
Cckar
cholecystokinin A receptor
ISS
5
54,089,724
54,098,943
RGD:4110818
RGD
G
Cckar
cholecystokinin A receptor
ISS
5
54,089,724
54,098,943
RGD:4110816
RGD
G
Cckbr
cholecystokinin B receptor
ISS
7
112,574,334
112,584,852
RGD:4110816
RGD
G
Cd40
CD40 antigen
IED
2
164,881,136
164,897,154
RGD:5490301
RGD
G
Cd40
CD40 antigen
ISS
2
164,881,136
164,897,154
RGD:5490524
RGD
G
Cldn4
claudin 4
ISS
5
135,420,993
135,422,804
RGD:2317592
RGD
G
Egf
epidermal growth factor
Disease_progression
ISS
3
129,380,493
129,458,240
RGD:2317644
RGD
G
Fasl
Fas ligand (TNF superfamily, member 6)
ISS
1
163,710,820
163,718,626
RGD:2317747
RGD
G
Fasl
Fas ligand (TNF superfamily, member 6)
ISS
1
163,710,820
163,718,626
RGD:2317741
RGD
G
Fgf2
fibroblast growth factor 2
ISS
3
37,247,575
37,303,752
RGD:2317756
RGD
G
Fgf2
fibroblast growth factor 2
Disease_progression
ISS
3
37,247,575
37,303,752
RGD:2317758
RGD
G
Fscn1
fascin homolog 1, actin bundling protein (Strongylocentrotus purpuratus)
Disease_progression
ISS
5
143,722,034
143,734,868
RGD:2317790
RGD
G
Gstp1
glutathione S-transferase, pi 1
Resistance
ISS
19
4,035,411
4,037,912
RGD:2317806
RGD
G
Gstp1
glutathione S-transferase, pi 1
ISS
19
4,035,411
4,037,912
RGD:2317809
RGD
G
Gstp1
glutathione S-transferase, pi 1
ISS
19
4,035,411
4,037,912
RGD:2317811
RGD
G
Igf1
insulin-like growth factor 1
IED
10
87,321,801
87,399,792
RGD:2317639
RGD
G
Igf1r
insulin-like growth factor I receptor
ISS
7
75,097,143
75,378,553
RGD:2317652
RGD
G
Igf1r
insulin-like growth factor I receptor
ISS
7
75,097,143
75,378,553
RGD:2317649
RGD
G
Il4
interleukin 4
ISS
11
53,425,962
53,432,167
RGD:2317264
RGD
G
Il4ra
interleukin 4 receptor, alpha
ISS
7
132,695,796
132,722,988
RGD:2317264
RGD
G
Ins2
insulin II
ISS
7
149,864,561
149,865,613
RGD:2317248
RGD
G
Krt7
keratin 7
Disease_progression
ISS
15
101,242,834
101,258,237
RGD:2317307
RGD
G
L1cam
L1 cell adhesion molecule
Severity
ISS
X
71,099,119
71,126,173
RGD:6483447
RGD
G
Mcm7
minichromosome maintenance deficient 7 (S. cerevisiae)
ISS
5
138,605,817
138,613,090
RGD:2317697
RGD
G
Mdm2
transformed mouse 3T3 cell double minute 2
Severity
ISS
10
117,125,961
117,147,772
RGD:2317416
RGD
G
Mdm2
transformed mouse 3T3 cell double minute 2
Onset
ISS
10
117,125,961
117,147,772
RGD:2317414
RGD
G
Men1
multiple endocrine neoplasia 1
ISS
19
6,334,979
6,340,894
RGD:2317294
RGD
G
Met
met proto-oncogene
ISS
6
17,413,957
17,523,980
RGD:2317530
RGD
G
Mgmt
O-6-methylguanine-DNA methyltransferase
ISS
7
144,086,294
144,319,871
RGD:2317664
RGD
G
Mgmt
O-6-methylguanine-DNA methyltransferase
Susceptibility
ISS
7
144,086,294
144,319,871
RGD:2317648
RGD
G
Mmp2
matrix metallopeptidase 2
Severity
ISS
8
95,351,227
95,377,319
RGD:2325746
RGD
G
Mmp9
matrix metallopeptidase 9
ISS
2
164,773,751
164,781,346
RGD:2325844
RGD
G
Mmp9
matrix metallopeptidase 9
ISS
2
164,773,751
164,781,346
RGD:2325830
RGD
G
Msln
mesothelin
Disease_progression
ISS
17
25,885,558
25,891,272
RGD:2326055
RGD
G
Msln
mesothelin
ISS
17
25,885,558
25,891,272
RGD:2326065
RGD
G
Muc1
mucin 1, transmembrane
Disease_progression
ISS
3
89,032,974
89,037,291
RGD:2324633
RGD
G
Muc1
mucin 1, transmembrane
ISS
3
89,032,974
89,037,291
RGD:2317983
RGD
G
Muc1
mucin 1, transmembrane
Disease_progression
ISS
3
89,032,974
89,037,291
RGD:2324616
RGD
G
Muc4
mucin 4
ISS
16
32,735,972
32,782,477
RGD:2324946
RGD
G
Muc4
mucin 4
Disease_progression
ISS
16
32,735,972
32,782,477
RGD:2324942
RGD
G
Muc5ac
mucin 5, subtypes A and C, tracheobronchial/gastric
ISS
7
148,974,916
149,005,040
RGD:2324986
RGD
G
Muc5ac
mucin 5, subtypes A and C, tracheobronchial/gastric
Disease_progression
ISS
7
148,974,916
149,005,040
RGD:2324907
RGD
G
Muc5b
mucin 5, subtype B, tracheobronchial
ISS
7
149,024,977
149,058,990
RGD:2324986
RGD
G
Nme1
NME/NM23 nucleoside diphosphate kinase 1
ISS
11
93,820,239
93,829,835
RGD:5132867
RGD
G
Nos2
nitric oxide synthase 2, inducible
IPM
11
78,734,361
78,773,626
RGD:2325254
RGD
G
Notch1
notch 1
IPM
2
26,313,422
26,359,342
RGD:2325323
RGD
G
Notch1
notch 1
IPM
2
26,313,422
26,359,342
RGD:2325324
RGD
G
Ntrk3
neurotrophic tyrosine kinase, receptor, type 3
Disease_progression
ISS
7
85,337,000
85,722,724
RGD:2325660
RGD
G
Ntrk3
neurotrophic tyrosine kinase, receptor, type 3
ISS
7
85,337,000
85,722,724
RGD:2325663
RGD
G
Palld
palladin, cytoskeletal associated protein
ISS
8
63,993,818
64,381,487
RGD:2325781
RGD
G
Pms1
postmeiotic segregation increased 1 (S. cerevisiae)
ISS
1
53,246,031
53,353,840
RGD:2324870
RGD
G
Pparg
peroxisome proliferator activated receptor gamma
Disease_progression
ISS
6
115,311,239
115,440,419
RGD:2317461
RGD
G
Ptgs2
prostaglandin-endoperoxide synthase 2
IPM
1
151,947,254
151,955,147
RGD:2317185
RGD
G
Rxra
retinoid X receptor alpha
Severity
ISS
2
27,532,721
27,618,839
RGD:2317461
RGD
G
Serpina1e
serine (or cysteine) peptidase inhibitor, clade A, member 1E
ISS
12
105,185,141
105,195,107
RGD:2317811
RGD
G
Slc2a2
solute carrier family 2 (facilitated glucose transporter), member 2
IEP
3
28,596,825
28,627,283
RGD:2324975
RGD
G
Smo
smoothened homolog (Drosophila)
ISS
6
29,685,497
29,711,366
RGD:2324981
RGD
G
Tgfb1
transforming growth factor, beta 1
Disease_progression
ISS
7
26,472,021
26,490,015
RGD:2325019
RGD
G
Tgfbr2
transforming growth factor, beta receptor II
Disease_progression
ISS
9
115,996,813
116,084,481
RGD:2317500
RGD
G
Tgfbr2
transforming growth factor, beta receptor II
IPM
9
115,996,813
116,084,481
RGD:2317498
RGD
G
Thbs1
thrombospondin 1
ISS
2
117,937,658
117,952,869
RGD:2325022
RGD
G
Thbs1
thrombospondin 1
Disease_progression
ISS
2
117,937,658
117,952,869
RGD:2325025
RGD
G
Tmprss3
transmembrane protease, serine 3
ISS
17
31,316,210
31,335,919
RGD:2325152
RGD
G
Tymp
thymidine phosphorylase
Disease_progression
ISS
15
89,202,362
89,207,467
RGD:2325155
RGD
G
Vhl
von Hippel-Lindau tumor suppressor
ISS
6
113,574,015
113,581,627
RGD:2325022
RGD
Gastrinoma
G
Igf1r
insulin-like growth factor I receptor
ISS
7
75,097,143
75,378,553
RGD:7242847
RGD
G
Men1
multiple endocrine neoplasia 1
ISS
19
6,334,979
6,340,894
RGD:2317354
RGD
G
Met
met proto-oncogene
Severity
ISS
6
17,413,957
17,523,980
RGD:2317605
RGD
G
Mgmt
O-6-methylguanine-DNA methyltransferase
ISS
7
144,086,294
144,319,871
RGD:2317340
RGD
G
Slc2a2
solute carrier family 2 (facilitated glucose transporter), member 2
ISS
3
28,596,825
28,627,283
RGD:2324977
RGD
G
Slc2a2
solute carrier family 2 (facilitated glucose transporter), member 2
ISS
3
28,596,825
28,627,283
RGD:2324976
RGD
Glucagonoma
G
Btc
betacellulin, epidermal growth factor family member
ISS
5
91,786,287
91,831,939
RGD:2326087
RGD
G
Men1
multiple endocrine neoplasia 1
IPM
19
6,334,979
6,340,894
RGD:2317288
RGD
G
Slc2a2
solute carrier family 2 (facilitated glucose transporter), member 2
ISS
3
28,596,825
28,627,283
RGD:2324977
RGD
G
Slc2a2
solute carrier family 2 (facilitated glucose transporter), member 2
ISS
3
28,596,825
28,627,283
RGD:2324976
RGD
G
Sstr4
somatostatin receptor 4
ISS
2
148,221,113
148,222,500
RGD:2324994
RGD
Insulinoma
G
Adm
adrenomedullin
ISS
7
117,771,183
117,773,333
RGD:2325319
RGD
G
Btc
betacellulin, epidermal growth factor family member
ISS
5
91,786,287
91,831,939
RGD:2326087
RGD
G
Cd40
CD40 antigen
IPM
2
164,881,136
164,897,154
RGD:5491180
RGD
G
Cxcl12
chemokine (C-X-C motif) ligand 12
ISS
6
117,118,553
117,131,386
RGD:2317608
RGD
G
Ins2
insulin II
ISS
7
149,864,561
149,865,613
RGD:2317266
RGD
G
Ins2
insulin II
ISS
7
149,864,561
149,865,613
RGD:2317268
RGD
G
Men1
multiple endocrine neoplasia 1
Disease_progression
IPM
19
6,334,979
6,340,894
RGD:2317292
RGD
G
Men1
multiple endocrine neoplasia 1
IPM
19
6,334,979
6,340,894
RGD:2317310
RGD
G
Men1
multiple endocrine neoplasia 1
IPM
19
6,334,979
6,340,894
RGD:2317288
RGD
G
Ncam1
neural cell adhesion molecule 1
ISS
9
49,310,243
49,607,174
RGD:2326080
RGD
G
Slc2a2
solute carrier family 2 (facilitated glucose transporter), member 2
ISS
3
28,596,825
28,627,283
RGD:2324977
RGD
G
Slc2a2
solute carrier family 2 (facilitated glucose transporter), member 2
ISS
3
28,596,825
28,627,283
RGD:2324976
RGD
G
Tgfa
transforming growth factor alpha
ISS
6
86,145,245
86,225,443
RGD:2317472
RGD
G
Tgfb1
transforming growth factor, beta 1
ISS
7
26,472,021
26,490,015
RGD:2325017
RGD
Melanoma-Pancreatic Cancer Syndrome
G
Cdkn2a
cyclin-dependent kinase inhibitor 2A
ISS
4
88,920,377
88,940,523
RGD:7240710
OMIM
Pancreatic carcinoma, familial
G
Apoa4
apolipoprotein A-IV
ISS
9
46,048,927
46,051,541
RGD:5685662
RGD
Term paths to the root one longest all shortest one shortest all one shortest and longest all longest
Path 1
Diseases
26136
Digestive System Diseases
2051
Pancreatic Diseases
582
Pancreatic Neoplasms
367
Adenoma, Islet Cell +
15
Carcinoma, Islet Cell +
12
Carcinoma, Pancreatic Ductal
77
Gastro-enteropancreatic neuroendocrine tumor
0
Islet cell tumor syndrome
0
Melanoma-Pancreatic Cancer Syndrome
1
Non functioning pancreatic endocrine tumor
0
Pancreatic Carcinoma
0
Pancreatic Lymphoma, Familial
0
Pancreatic adenoma
0
Pancreatic cancer, adult
0
Pancreatic carcinoma, familial
1
Pancreatoblastoma
0
Pheochromocytoma Islet Cell Tumor Syndrome
0
Path 2
Diseases
26136
Neoplasms
4715
Neoplasms by Site
3438
Endocrine Gland Neoplasms
781
Pancreatic Neoplasms
367
Adenoma, Islet Cell +
15
Carcinoma, Islet Cell +
12
Carcinoma, Pancreatic Ductal
77
Gastro-enteropancreatic neuroendocrine tumor
0
Islet cell tumor syndrome
0
Melanoma-Pancreatic Cancer Syndrome
1
Non functioning pancreatic endocrine tumor
0
Pancreatic Carcinoma
0
Pancreatic Lymphoma, Familial
0
Pancreatic adenoma
0
Pancreatic cancer, adult
0
Pancreatic carcinoma, familial
1
Pancreatoblastoma
0
Pheochromocytoma Islet Cell Tumor Syndrome
0